Mark Baldry
Insider Reports History
- Location
- Cranbury, NJ
- Signature
- /s/ Adam S. Mostafa, attorney-in-fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Mark Baldry:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc | Chief Commercial Officer | Common Stock | 25,337 | $62,886 | $2.48 | 16 May 2025 | Direct |
Insider Reports Filed by Mark Baldry
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | 16 May 2025 | 1 | +$2,561 | 4/A | Chief Commercial Officer | 03 Jun 2025, 17:01 |
| XFOR | X4 Pharmaceuticals, Inc | 23 Jan 2025 | 2 | -$13,241 | 4 | Chief Commercial Officer | 27 Jan 2025, 18:15 |
| XFOR | X4 Pharmaceuticals, Inc | 04 Oct 2024 | 2 | -$6,506 | 4 | Chief Commercial Officer | 08 Oct 2024, 16:44 |
| XFOR | X4 Pharmaceuticals, Inc | 17 May 2024 | 3 | +$19,252 | 4 | Chief Commercial Officer | 14 Feb 2025, 16:08 |
| XFOR | X4 Pharmaceuticals, Inc | 13 Feb 2024 | 1 | $0 | 4 | Chief Commercial Officer | 16 Feb 2024, 17:09 |
| XFOR | X4 Pharmaceuticals, Inc | 01 Nov 2023 | 1 | -$7,488 | 4 | Chief Commercial Officer | 03 Nov 2023, 16:39 |
| XFOR | X4 Pharmaceuticals, Inc | 31 Oct 2023 | 1 | $0 | 4 | Chief Commercial Officer | 02 Nov 2023, 17:00 |
| XFOR | X4 Pharmaceuticals, Inc | 03 Nov 2022 | 1 | +$644,490 | 4 | Chief Commercial Officer | 04 Nov 2022, 16:18 |
| XFOR | X4 Pharmaceuticals, Inc | 03 Nov 2022 | 0 | $0 | 3 | Chief Commercial Officer | 04 Nov 2022, 16:15 |